Terns Pharmaceuticals, Inc. short interest in 2022
In 2022, Terns Pharmaceuticals, Inc.'s disclosed short interest ran from 1.71% of shares outstanding on 14 Jan 2022 to 3.21% on 30 Dec 2022, a change of +1.50 percentage points. The year's high was 3.21% on 30 Dec 2022 and its low 0.23% on 15 Aug 2022, averaging 1.64% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.65 days on 15 Mar 2022. Full history: Terns Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.71% (14 Jan 2022)
- End of year
- 3.21% (30 Dec 2022)
- Change
- +1.50 pp
- High
- 3.21% (30 Dec 2022)
- Low
- 0.23% (15 Aug 2022)
- Average
- 1.64%
- Highest days to cover
- 9.65 (15 Mar 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.71% | 6.31 | |
| 31 Jan 2022 | 1.41% | 7.77 | |
| 15 Feb 2022 | 1.60% | 7.95 | |
| 28 Feb 2022 | 1.60% | 7.25 | |
| 15 Mar 2022 | 1.45% | 9.65 | results (8-K), 10-K filed |
| 31 Mar 2022 | 1.40% | 5.57 | |
| 14 Apr 2022 | 1.59% | 4.27 | |
| 29 Apr 2022 | 1.47% | 3.26 | |
| 13 May 2022 | 1.90% | 5.44 | |
| 31 May 2022 | 1.91% | 1.45 | 10-Q filed, results (8-K) |
| 15 Jun 2022 | 1.98% | 2.78 | |
| 15 Aug 2022 | 0.23% | 1.00 | 10-Q filed, results (8-K) |
| 15 Nov 2022 | 1.35% | 5.71 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 1.45% | 1.00 | |
| 15 Dec 2022 | 2.04% | 7.40 | |
| 30 Dec 2022 | 3.21% | 1.76 |
See also: Terns Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.